Massachusetts Financial Services
AGIO icon

Massachusetts Financial Services’s Agios Pharmaceuticals AGIO Stock Holding History

Massachusetts Financial Services’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,116
Closed -$201K – 861
2021
Q4 		$201K Sell
6,116
-124
-2% -$4.99K ﹤0.01% 884
2021
Q3 		$288K Sell
6,240
-83
-1% -$4.01K ﹤0.01% 892
2021
Q2 		$348K Buy
+6,323
New +$354K ﹤0.01% 889

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Massachusetts Financial Services's AGIO Position: Q1 2022 in Review

Massachusetts Financial Services sold out of Agios Pharmaceuticals (AGIO) in Q1 2022, closing a stake of 6,116 shares — an estimated $201K sold.

Massachusetts Financial Services first reported a position in AGIO in Q2 2021 and held it in 3 quarters. The position peaked at $348K in Q2 2021. 161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Massachusetts Financial Services reported no remaining Agios Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 6,116 Agios Pharmaceuticals shares in Q1 2022, an estimated $201K.
  • Massachusetts Financial Services first reported a position in Agios Pharmaceuticals in Q2 2021 and held it in 3 quarters.
  • Massachusetts Financial Services's Agios Pharmaceuticals position peaked at $348K in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Massachusetts Financial Services's 13F filing for Q1 2022, filed 11 May 2022.